Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system-Reference-Cited by-同舟云学术

Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system

Published:2023-03-20 Issue:5 Volume:23 Page:499-510
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

De la Cuadra-Grande Alberto¹^ORCID,Rioja-Zuazu Jorge²,Domínguez-Esteban Mario³,Torres Esperanza⁴,Blissett Rob⁵,Woodward Emily⁶,Oyagüez Itziar¹^ORCID,Fernández-Arjona Manuel⁷

Affiliation:

1. Pharmacoeconomics & Outcomes Research Iberia (PORIB), Madrid, Spain

2. Urology Department, Clínica Universitaria de Navarra, Navarra, Spain

3. Urology Department, Hospital Marqués de Valdecilla, Cantabria, Spain

4. Health Economics & Market Access, Boston Scientific Inc, Madrid, Spain

5. Health Economics & Economic Evaluation, MedTech Economics Ltd, Winchester, UK

6. Health Economics & Market Access, Boston Scientific AG, Solothurn, Switzerland

7. Urology Department, Hospital Universitario del Henares, Madrid, Spain

Funder

Boston Scientific, Inc

Publisher

Informa UK Limited